FindTrial
Sign In

To find out the prevalence of Anxiety, Depressive symptoms and Substance use in persons with Schizophrenia.

Prevalence of Anxiety, Depressive Symptoms and Substance Use in persons with Schizophrenia - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/11/059495
Enrollment
170
Registered
2023-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F20- Schizophrenia

Interventions

Intervention1: NIL: NIL

Sponsors

Government Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosis of Schizophrenia according to ICD-11. 2. Age group 18- 60 years. 3. Any gender. 4. Duration of Illness less than 5

Exclusion criteria

Exclusion criteria: 1. Individuals with intellectual disability, uncooperative and violent patient. 2. Patient’s not giving consent. 3. Actively Suicidal patients

Design outcomes

Primary

MeasureTime frame
To estimate the Prevalence of Anxiety, Depressive symptoms and Substance use in persons with Schizophrenia.Timepoint: Baseline—

Secondary

MeasureTime frame
To assess the frequency & severity of Anxiety, Depressive symptoms & Substance Use in persons with Schizophrenia.Timepoint: Baseline;To find correlation among Anxiety, Depressive symptoms & Substance Use with severity of Schizophrenia.Timepoint: Baseline—

Countries

India

Contacts

Public ContactDr Ajeet Sidana

Government Medical College and Hospital, Sector-32, Chandigarh

ajeetsidana@hotmail.com9056422679

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026